Normal human melanocytes that express a bFGF transgene still require exogenous bFGF for growth in vitro.

The expression of basic fibroblast growth factor (bFGF) has been implicated as an important factor in the development of malignant melanoma. The timing of this expression suggests that bFGF plays a role early in melanoma tumor progression. Benign nevi produce bFGF, and cells cultured from these lesions show a loss of dependence on exogenous bFGF for growth. We have examined the effects of constitutive bFGF expression on the in vitro growth requirements of normal human melanocytes. bFGF was overexpressed in normal human epidermal melanocytes through genomic insertion of a human bFGF cDNA in a retroviral vector. These melanocytes produced the 18 kDa bFGF isoform as well as the higher molecular weight isoforms. The bFGF was not released into the culture medium, but it was present in the cell nucleus. The bFGF produced by these cells was mitogenic for 3T3 fibroblasts and therefore possessed functional activity; however, melanocytes producing bFGF had the same appearance and growth patterns as those infected with control virus or uninfected melanocytes. Expression of bFGF did not confer independence from the exogenous mitogen, nor would these cells form colonies in a soft-agar medium. These results indicate that expression of bFGF alone is not enough to cause aberrant growth of normal human melanocytes.

[1]  J. Kirkwood,et al.  Molecular analysis of melanoma precursor lesions. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[2]  D. Hanahan,et al.  Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis , 1996, Cell.

[3]  J. C. Fox,et al.  Antisense Inhibition of Basic Fibroblast Growth Factor Induces Apoptosis in Vascular Smooth Muscle Cells (*) , 1996, The Journal of Biological Chemistry.

[4]  E. Calleja,et al.  Elevated intracellular level of basic fibroblast growth factor correlates with stage of chronic lymphocytic leukemia and is associated with resistance to fludarabine. , 1996, Blood.

[5]  P. Davol,et al.  Autocrine down-regulation of basic fibroblast growth factor receptors causes mitotoxin resistance in a human melanoma cell line. , 1995, The Journal of investigative dermatology.

[6]  C. Elmets,et al.  Reduced growth factor requirements and accelerated cell-cycle kinetics in adult human melanocytes transformed with SV40 large T antigen. , 1995, The Journal of investigative dermatology.

[7]  D. Rifkin,et al.  Differential modulation of cell phenotype by different molecular weight forms of basic fibroblast growth factor: possible intracellular signaling by the high molecular weight forms , 1995, The Journal of cell biology.

[8]  W. Silvers,et al.  Ultraviolet radiation-induced malignant skin melanoma in melanoma-susceptible transgenic mice. , 1994, Cancer research.

[9]  J. Schwartz,et al.  Basic fibroblast growth factor protects endothelial cells against radiation-induced programmed cell death in vitro and in vivo. , 1994, Cancer research.

[10]  M. Ueda,et al.  Stable and strong expression of basic fibroblast growth factor in naevus cell naevus contrasts with aberrant expression in melanoma , 1994, The British journal of dermatology.

[11]  N. S. Mcnutt,et al.  Differential expression of basic fibroblast growth factor (bFGF) in melanocytic lesions demonstrated by in situ hybridization. Implications for tumor progression. , 1994, The American journal of pathology.

[12]  W. Silvers,et al.  Transgenic mouse model of malignant skin melanoma. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[13]  A. Halpern,et al.  Growth regulation of cultured human nevus cells. , 1993, The Journal of investigative dermatology.

[14]  S. Jhanwar,et al.  Malignant transformation of human melanocytes: induction of a complete melanoma phenotype and genotype. , 1992, Oncogene.

[15]  M. Herlyn,et al.  Inhibition of the fibroblast growth factor receptor 1 (FGFR-1) gene in human melanocytes and malignant melanomas leads to inhibition of proliferation and signs indicative of differentiation. , 1992, Oncogene.

[16]  M. Graham,et al.  Differences in basic fibroblast growth factor RNA and protein levels in human primary melanocytes and metastatic melanoma cells. , 1992, Cancer research.

[17]  Y. Masamune,et al.  Direct effect of basic fibroblast growth factor on gene transcription in a cell-free system. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[18]  D. Hanahan,et al.  Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma , 1991, Cell.

[19]  A. Albino,et al.  Induction of growth factor RNA expression in human malignant melanoma: markers of transformation. , 1991, Cancer research.

[20]  H. Prats,et al.  Potential oncogenic effects of basic fibroblast growth factor requires cooperation between CUG and AUG-initiated forms. , 1991, Cell regulation.

[21]  M. Herlyn,et al.  Constitutive expression of multiple growth factor genes by melanoma cells but not normal melanocytes. , 1991, The Journal of investigative dermatology.

[22]  R. Halaban,et al.  Localization of basic fibroblast growth factor mRNA in melanocytic lesions by in situ hybridization. , 1991, The Journal of investigative dermatology.

[23]  H. Prats,et al.  Alternative initiation of translation determines cytoplasmic or nuclear localization of basic fibroblast growth factor , 1991, Molecular and cellular biology.

[24]  R. Florkiewicz,et al.  Multiple forms of bFGF: differential nuclear and cell surface localization. , 1991, Growth factors.

[25]  M. Thayer,et al.  Regulation of chimeric phosphoenolpyruvate carboxykinase genes by the trans-dominant locus TSE1 , 1990, Molecular and cellular biology.

[26]  V. Baldin,et al.  Translocation of bFGF to the nucleus is G1 phase cell cycle specific in bovine aortic endothelial cells. , 1990, The EMBO journal.

[27]  M. Herlyn,et al.  Proliferation of human malignant melanomas is inhibited by antisense oligodeoxynucleotides targeted against basic fibroblast growth factor. , 1989, The EMBO journal.

[28]  R. Halaban,et al.  Transformation of murine melanocytes by basic fibroblast growth factor cDNA and oncogenes and selective suppression of the transformed phenotype in a reconstituted cutaneous environment , 1989, The Journal of cell biology.

[29]  Miller Ad,et al.  Improved Retroviral Vectors for Gene Transfer and Expression , 1989 .

[30]  A. Sommer,et al.  Human basic fibroblast growth factor gene encodes four polypeptides: three initiate translation from non-AUG codons. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[31]  O. Witte,et al.  The BCR-ABL oncogene transforms Rat-1 cells and cooperates with v-myc , 1989, Molecular and cellular biology.

[32]  T. Maciag,et al.  The heparin-binding (fibroblast) growth factor family of proteins. , 1989, Annual review of biochemistry.

[33]  M. Herlyn,et al.  Regulatory factors that determine growth and phenotype of normal human melanocytes. , 1988, Experimental cell research.

[34]  R. Halaban,et al.  Basic fibroblast growth factor from human keratinocytes is a natural mitogen for melanocytes , 1988, The Journal of cell biology.

[35]  B. Kwon,et al.  bFGF as an autocrine growth factor for human melanomas. , 1988, Oncogene research.

[36]  M. Keating,et al.  Autocrine stimulation of intracellular PDGF receptors in v-sis-transformed cells. , 1988, Science.

[37]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[38]  J. Fiddes,et al.  Human basic fibroblast growth factor: nucleotide sequence and genomic organization. , 1986, The EMBO journal.

[39]  A. Miller,et al.  Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production , 1986, Molecular and cellular biology.

[40]  P. Duray,et al.  Human melanocytes cultured from nevi and melanomas. , 1986, The Journal of investigative dermatology.

[41]  P. Nowell,et al.  Characteristics of cultured human melanocytes isolated from different stages of tumor progression. , 1985, Cancer research.

[42]  D. Baltimore,et al.  Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus , 1983, Cell.

[43]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.